Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berko Milleit

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Neuroimage|May 19, 2010
Phospholipase A2 activity is associated with structural brain changes in schizophreniaStefan Smesny, Berko Milleit, Igor Nenadic, et al.
Gait & Posture|November 9, 2004
Classification of equinus in ambulatory children with cerebral palsy-discrimination between dynamic tightness and fixed contractureErnst B Zwick, Lutz Leistritz, Berko Milleit, et al.
Frontiers in Cellular Neuroscience|March 26, 2016
Serum S100B Protein is Specifically Related to White Matter Changes in SchizophreniaBerko Milleit, Stefan Smesny, Matthias Rothermundt, et al.
Neuroscience|November 21, 2021
Brain Derived Neurotrophic Factor Deficiency is Associated with Cognitive Impairment and Elevated Phospholipase A2 Activity in Plasma of MiceMichaela Schmidt, Andrea Carlo Rossetti, Christiane Brandwein, et al.
Schizophrenia Research|January 28, 2017
Effects of omega-3 PUFA on immune markers in adolescent individuals at ultra-high risk for psychosis - Results of the randomized controlled Vienna omega-3 studyStefan Smesny, Berko Milleit, Miriam R Schaefer, et al.
Schizophrenia Research|August 11, 2015
Glutamatergic dysfunction linked to energy and membrane lipid metabolism in frontal and anterior cingulate cortices of never treated first-episode schizophrenia patientsStefan Smesny, Alexander Gussew, Natalie Joan Biesel, et al.
Schizophrenia Bulletin|May 17, 2012
Skin ceramide alterations in first-episode schizophrenia indicate abnormal sphingolipid metabolismStefan Smesny, Christian E H Schmelzer, Anke Hinder, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|August 12, 2015
Effects of omega-3 PUFA on the vitamin E and glutathione antioxidant defense system in individuals at ultra-high risk of psychosisStefan Smesny, Berko Milleit, Miriam R Schaefer, et al.
Neuroscience|December 22, 2016
Polyunsaturated fatty acid biostatus, phospholipase A<sub>2</sub> activity and brain white matter microstructure across adolescenceRobert K McNamara, Philip R Szeszko, Stefan Smesny, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|December 15, 2010
Phospholipase A₂ activity in first episode schizophrenia: associations with symptom severity and outcome at week 12Stefan Smesny, Christina Kunstmann, Sebastian Kunstmann, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Neuroimage|May 19, 2010
Phospholipase A2 activity is associated with structural brain changes in schizophreniaStefan Smesny, Berko Milleit, Igor Nenadic, et al.
Gait & Posture|November 9, 2004
Classification of equinus in ambulatory children with cerebral palsy-discrimination between dynamic tightness and fixed contractureErnst B Zwick, Lutz Leistritz, Berko Milleit, et al.
Frontiers in Cellular Neuroscience|March 26, 2016
Serum S100B Protein is Specifically Related to White Matter Changes in SchizophreniaBerko Milleit, Stefan Smesny, Matthias Rothermundt, et al.
Neuroscience|November 21, 2021
Brain Derived Neurotrophic Factor Deficiency is Associated with Cognitive Impairment and Elevated Phospholipase A2 Activity in Plasma of MiceMichaela Schmidt, Andrea Carlo Rossetti, Christiane Brandwein, et al.
Schizophrenia Research|January 28, 2017
Effects of omega-3 PUFA on immune markers in adolescent individuals at ultra-high risk for psychosis - Results of the randomized controlled Vienna omega-3 studyStefan Smesny, Berko Milleit, Miriam R Schaefer, et al.
Schizophrenia Research|August 11, 2015
Glutamatergic dysfunction linked to energy and membrane lipid metabolism in frontal and anterior cingulate cortices of never treated first-episode schizophrenia patientsStefan Smesny, Alexander Gussew, Natalie Joan Biesel, et al.
Schizophrenia Bulletin|May 17, 2012
Skin ceramide alterations in first-episode schizophrenia indicate abnormal sphingolipid metabolismStefan Smesny, Christian E H Schmelzer, Anke Hinder, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|August 12, 2015
Effects of omega-3 PUFA on the vitamin E and glutathione antioxidant defense system in individuals at ultra-high risk of psychosisStefan Smesny, Berko Milleit, Miriam R Schaefer, et al.
Neuroscience|December 22, 2016
Polyunsaturated fatty acid biostatus, phospholipase A<sub>2</sub> activity and brain white matter microstructure across adolescenceRobert K McNamara, Philip R Szeszko, Stefan Smesny, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|December 15, 2010
Phospholipase A₂ activity in first episode schizophrenia: associations with symptom severity and outcome at week 12Stefan Smesny, Christina Kunstmann, Sebastian Kunstmann, et al.
Pageof 2